Skip to search formSkip to main contentSkip to account menu

Gemzar

National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

Gemcitabine hydrochloridegemcitabine
LY 188011gemcitabine 200 MG Injection [Gemzar]gemcitabine Injection [Gemzar]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer.
2004
2004
Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).
Review
2003
Review
2003
Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib.
In phase I trials in healthy volunteers and patients with refractory cancers, erlotinib (Tarceva) was well tolerated and showed… 
2002
2002
Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer
This phase II study evaluated the activity of gemcitabine (Gemzar) plus cisplatin (Platinol) as first-line treatment of advanced… 
2002
2002
Irinotecan and gemcitabine in patients with solid tumors: phase I trial.
Using a day 1 and 8, every-3-week schedule, our purpose was to determine the maximum tolerated dose of irinotecan (CPT-11… 
2001
2001
Gemcitabine plus cisplatin in breast cancer.
In recent years, the clinical application of paclitaxel (Taxol), docetaxel (Taxotere), vinorelbine (Navelbine), and trastuzumab… 
2001
2001
Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer. Final results from a phase II trial.
In a single-center, open, phase II trial, we assessed the toxicity and activity of a triple combination therapy--doxorubicin at… 
2001
2001
Gemcitabine and paclitaxel as salvage therapy in metastatic breast cancer.
In a phase II trial, 29 patients with anthracycline-pretreated or anthracycline-resistant metastatic breast cancer in whom… 
2000
2000
Interim results of a phase III trial. Paclitaxel/carboplatin vs paclitaxel/gemcitabine in advanced non-small-cell lung cancer.
The Hellenic Cooperative Oncology Group conducted a randomized phase III trial to compare paclitaxel (Taxol) 200 mg/m2 i.v. 3… 
1999
1999
Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer.
Gemcitabine (Gemzar) has a significant impact upon survival and quality of life for patients with pancreatic cancer, compared… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)